Icotinib Following Chemotherapy Versus Chemotherapy as Adjuvant Therapy in Stage IIA-IIIA NSCLC With EGFR Mutation
Clinical trial NCT01996098 · TERMINATED
Trial details
- NCT number
- NCT01996098
- Sponsor
- Sun Yat-sen University
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2021-12-31
- Enrollment
- 251
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.